Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 701 - 750 of 759 results
- Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.
- Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
- Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human beta3 Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety.
- In silico prediction of novel phosphodiesterase type-5 inhibitors derived from Sildenafil, Vardenafil and Tadalafil.
- Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity.
- Interleukin-10 attenuates TNF-alpha-induced interleukin-6 production in endometriotic stromal cells.
- Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.
- Celecoxib for Treatment of Nocturia Caused by Benign Prostatic Hyperplasia: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study.
- Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
- Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats.
- Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.
- Calcium Dobesilate for the Treatment of Erectile Dysfunction in Men with Diabetes Mellitus.
- Effect of Dutasteride on Intraprostatic Androgen Levels in Men With Benign Prostatic Hyperplasia or Prostate Cancer.
- The effectiveness of tamsulosin in treating women with voiding difficulty.
- Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study.
- Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome.
- Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy.
- Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
- Synthesis and biological affinity of new imidazo- and indol-arylpiperazine derivatives: Further validation of a pharmacophore model for alpha(1)-adrenoceptor antagonists.
- Long-term safety, tolerability, and efficacy of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder.
- Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study.
- Erythropoietin Promotes Erection Recovery After Nerve-Sparing Radical Retropubic Prostatectomy: A Retrospective Analysis.
- Role of Increased Penile Expression of Transforming Growth Factor-beta1 and Activation of the Smad Signaling Pathway in Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats.
- The Relationship between Erectile Dysfunction and Lower Urinary Tract Symptoms and the Role of Phosphodiesterase Type 5 Inhibitors.
- Tolterodine Immediate Release Improves Sexual Function in Women with Overactive Bladder.
- Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy.
- Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH.
- A Positive Modulator of KCa2 and KCa3 Channels, NS4591, Inhibits Bladder Afferent Firing in vitro and Bladder Overactivity in vivo.
- A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.
- Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals.
- High dosage sildenafil induces hearing impairment in mice.
- Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-controlled, Double-blind, Crossover Study with Tolterodine and Darifenacin in Healthy Participants >=50 Years.
- Association between 5-alpha reductase inhibition and risk of hip fracture.
- The role of melanin-concentrating hormone-1 (MCH1) receptors in the voiding reflex in rats.
- Design, Synthesis, Biological Evaluation and Pharmacokinetics of Bis(hydroxyphenyl) substituted Azoles, Thiophenes, Benzenes, and Aza-Benzenes as Potent and Selective Nonsteroidal Inhibitors of 17beta-Hydroxysteroid Dehydrogenase Type 1 (17beta-HSD1).
- Chronic sildenafil (Viagra) administration reduces anxiety in intact and castrated male rats.
- Structure-activity study in the class of 6-(3'-hydroxyphenyl)naphthalenes leading to an optimization of a pharmacophore model for 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors.
- CXCL10 blockade protects mice from cyclophosphamide-induced cystitis.
- Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and cardiovascular comorbidities.
- Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists.
- Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunction.
- Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial.
- Trazodone for the Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors: A Preliminary Open-Label Study.
- Nicorandil, a Potassium Channel Opener and Nitric Oxide Donor, Improves the Frequent Urination without Changing the Blood Pressure in Rats with Partial Bladder Outlet Obstruction.
- Expressions of voltage-gated K+ channel 2.1 and 2.2 in rat bladder with detrusor hyperreflexia.
- Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.
- Development of a biological screening system for the evaluation of highly active and selective 17beta-HSD1-inhibitors as potential therapeutic agents.
- Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
- Treatment With Solifenacin Increases Warning Time and Improves Symptoms of Overactive Bladder: Results From VENUS, a Randomized, Double-Blind, Placebo-Controlled Trial.
- Discovery of Sodium R-(+)-4-{2-[5-(2-Fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (Elagolix), a Potent and Orally Available Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor.